On Friday 16th of December there will be a webinar by EPASG titled "To TDM or not to TDM: pitfalls and success of MIPD of antibiotics in special populations" 12.00 -13:00 CET.
12:00-12:25: beta lactams and ciprofloxacin by Birgit Koch
12:25-12:45: vancomycin and linezolid by Sonia Luque Pardos
The dial-in info is shared via the newsletter!
Positions available:
(1) A postdoc position is available
The Lab of Dr. Zack Bulman in Chicago, IL, USA is looking for a postdoctoral fellow in antimicrobial pharmacology and PK/PD. Kindly refer to this link for the application: https://uic.csod.com/ux/ats/careersite/1/home/requisition/1950?c=uic
Please reach out to Zack (This email address is being protected from spambots. You need JavaScript enabled to view it.) with any questions.
(2) Postdoctoral position at Bayer AG
A postdoctoral placement in an industrial environment in Bayer facilities (Frankfurt, Germany) is available starting in 12/2023.
2 mandatory prerequisites to be eligible for the program:
a) Australian or New Zealand citizenship
b) PhD thesis in relevant field being submitted latest Oct 2023
Respective applications, consisting of cover letter, curriculum vitae and a scientific dossier covering their synthetic / biochemical topics from Bachelor-, Master-, PhD-work (maximum 5 pages in total), are to be sent to This email address is being protected from spambots. You need JavaScript enabled to view it. by 15th February 2023 in order to allow time for preparation of interviews.
Dear ISAP members,
We are pleased to share the first circular of our program for the upcoming ISAP-EPASG Meeting on November 12-13 2021. The meeting will start at 1.00 PM CET on November 12 and finish at 14.15PM on November 13. Please find the current version of the program here.
Call for abstracts for the Young Investigator Session
As per ISAP tradition, also the upcoming meeting will contain a Young Investigator Session, which is organised by Alina Nussbaumer-Pröll (Vienna, Austria) and Elisabet Nielsen (Uppsala, Sweden). We encourage all Young Investigators to actively contribute by submitting abstracts for a 5–10-minute oral talk (depending on the number of participants) about your current data or project followed by 2–5-minutes questions and answers. You are also welcomed to present data that has been already approved at ECCMID 2021. To submit abstracts, we would ask you to send an e-mail with your abstract (in any format) to This email address is being protected from spambots. You need JavaScript enabled to view it. until the 10th of October. Abstracts will be reviewed by the scientific committee. Please include your affiliation and full name.
Best regards,
ISAP Council
Dear ISAP members!
As the situation in Europe is steadily stabilizing after the pandemic winter, we are pleased to share with you information on two upcoming events around the ECCMID meeting in April 2022:
EPASG Pre-ECCMID Course
Prior to ECCMID, on 21-22 April 2022, EPASG is hosting a on-site workshop titled "Optimised dosing of antibiotics - understanding PK/PD, clinical breakpoints, and therapeutic drug monitoring" in Oerias (close to Lisbon), Portugal. ESCMID indicated that the course is filling up quickly. The program can be found here. Register here, if you are interested to join!
ISAP Meeting
Right after the EPASG course on 22 April 2022, and hence on the evening before ECCMID, we will hold an ISAP Scientific Meeting from 16.30 to approx. 20.00 in the same hotel (Lagoas Park, Oerias) as the EPASG course, in Oerias, Portugal. Registration is now closed.
Location (ca. 20 mins from Lisbon airport/Lisbon city centre by taxi):
Lagoas Park Hotel
Rua Encosta das Lagoas
2740-245 Porto Salvo, Portugal
Program:
16.15-16.30 Arrival and Welcome
16.30-17.15 ISAP General Meeting
17.15-19.00 Young Investigator Session
|
First name |
Last Name |
Title |
|
Aneeq |
Farooq |
Interaction screening of ceftazidime-avibactam and tigecycline against six clinical and nine isogenic E. coli and K. pneumoniae strains expressing carbapenemases |
|
Wisse |
Van Os |
Impact of individual ascitic fluids on bacterial growth and ceftriaxone effect in an in vitro model of spontaneous bacterial peritonitis |
|
Nicole |
Zimmermann |
Integrated in vitro approach to understand the exposure-effect relationship of fosfomycin against Escherichia coli |
|
Amaury |
O'Jeanson |
A model-based analysis of pharmacokinetic-pharmacodynamic (PK/PD) indices of avibactam against β-lactamase-producing Gram-negative bacteria |
|
Jinxin |
Zhao |
PhageGE: An Interactive Web-based R Shiny Application for Bacteriophage Pharmacology |
|
Sue |
Nang |
Elucidating the pharmacokinetics/ pharmacodynamics of bacteriophage therapy against Pseudomonas aeruginosa using a mouse bacteraemia model |
|
Romain |
Aubry |
Semi-mechanistic PKPD modelling of ceftazidime/avibactam and colistin combination against five multidrug resistant Klebsiella pneumoniae isolates |
|
Mathilde |
Lacroix |
In vitro PK/PD modelling of polymyxin B against resistant strain of A. baumannii in presence of mucin |
|
Matthias |
Gijsen |
Model-based TDM of vancomycin: a retrospective comparison with routine TDM-based dosing |
|
Gert-Jan |
Wijnant |
Pharmacokinetics and PK/PD of temocillin in non-ICU urinary tract infection patients with various stages of renal insufficiency |
|
Tim |
Ewoldt |
Large variability of unbound active fraction of ceftriaxone in contrast to ciprofloxacin in plasma of critically ill patients |
|
Maria |
Sanz Codina |
Relationship between pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill COVID-19 patients with documented Gram-negative superinfections treated with meropenem continuous infusion |
19.00-20.00 Reception with light food and beverages
We hope to see you in Portugal, soon!
Best regards
ISAP Council
After our first successful virtual meeting in February, we would like to invite you to our 2nd virtual ISAP meeting:
The meeting will take place in the US/European time zone on May 26 2021 4PM - 6PM CEST and will be held online.
The meeting will start with a keynote presentation by Dr. Sujata Bhavnani (NY, USA) with a presentation titled:
"Antimicrobial Therapy: Precision Medicine and Beyond"
| Presenter | Title |
| Sue Nang | Polymyxins: 'Pseudo'-resistance in Klebsiella pneumoniae |
| Johanna Seeger | Quantification of persister formation of Escherichia coli lerveraging electronic cell counting and semi-mechanistic pharmacokinetic/pharmacodynamic modelling |
| Lisa Amann | Continuous infusion of tigecycline as an improved treatment option? Insights from a hollow fiber study |
| Karol Sokolowski | Evaluating Glutathione-conjugated Hydrogels as Localized Antibiotic Delivery Vehicles for Treatment of Bacterial Infections |
| David Busse | Probability of target attainment of antibiotics in obese patients: Do conventional pharmacokinetic/pharmacodynamic targets adequately capture target-site penetration?" |
Dial-in information are shared via the Newsletter - check your inbox!